| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure | 
|---|---|---|---|---|
| 41788 | CB-6644 | 2316817-88-4 | 96.33% |  | 
| CB-6644 acts as a noncompetitive ATPase inhibitor. Additionally, it can inhibit RUVBL | ||||
| 24107 | LXH-3-71 | 2251753-65-6 | ≧97.0% |  | 
| LXH-3-71 isnovel "molecular glue"that induces the interaction between PHGDH | ||||
| 20645 | CP-506 ( Synonyms: SN-36506 ) | 2227304-19-8 | 98% Min. |  | 
| CP-506 (SN-36506) is an hypoxia-activated prodrug of a DNA-alkylating nitrogen mustar | ||||
| 822223 | Venglustat ( ibiglustat ) | 1401090-53-6 | ≧98.0% | _1401090-53-6.png) | 
| Venglustat(ibiglustat)is an oral inhibitor of an enzyme called glucosylceramide synth | ||||
| 822224 | RP-5063(Brilaroxazine) | 1239729-06-6 | ≧98.0% | _1239729-06-6.png) | 
| RP-5063(Brilaroxazine) is a multimodal modulator of serotonin and dopamine recept | ||||
| 822225 | Cadisegliatin (TTP-399) | 859525-02-3 | ≧98.0% |  | 
| Cadisegliatin(TTP-399) is a potential liver-selective glucokinase (GK) activator for | ||||
| 231106 | PDS-0330 | 2904682-19-3 | ≧98.0% |  | 
| PDS0330 is a new claudin-1 inhibitor in Colorectal Cancer. | ||||
| 20258 | CRT0273750 | 1979939-16-6 | ≧98.0% |  | 
| CRT0273750 modulates LPA levels in plasma and is suitable for in vivo studies. | ||||
| 20259 | Elinzanetant ( NT-814 ) | 929046-33-3 | ≧98.0% |  | 
| Elinzanetant, previously known as NT-814 (45), is a dual NK1,3R antagonist and theref | ||||
| 52002 | K-7174 dihydrochloride | 191089-60-8 | 98% |  | 
| K-7174 dihydrochloride is a novel cell adhesion inhibitor; inhibits the expression of | ||||
| 18381 | JPH203 HCl ( Nanvuranlat ) | 1597402-27-1 | ≧95.0% | _1597402-27-1.png) | 
| JPH203, also known as KYT-0353, is a potent and selective LAT1 selective ( L-type ami | ||||
| 615201 | CLEFMA | 1246964-32-8 | 98% Min. |  | 
| CLEFMA has anti-proliferative activity in H441 cells. CLEFMA may induce autophagic ce | ||||
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2025 Wuhan Sun-shine Bio-technology Corporation Limited. | 鄂ICP备17005301号-1
